These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 69601

  • 1. Characterization of the thyrotropin receptor and its involvement in Graves' disease.
    Kohn LD.
    Horiz Biochem Biophys; 1977; 3():123-63. PubMed ID: 69601
    [No Abstract] [Full Text] [Related]

  • 2. Gonadotrophin receptors: characteristics and clinical applications.
    Davies TF, Dufau ML, Catt KJ.
    Clin Obstet Gynaecol; 1978 Aug; 5(2):329-62. PubMed ID: 213227
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Binding of THS by normal and TSI-containing globulins.
    Bíró J.
    Endocrinol Exp; 1980 Mar; 14(1):9-16. PubMed ID: 6249567
    [Abstract] [Full Text] [Related]

  • 6. The adenylate cyclase-cyclic AMP system in Graves' disease.
    Field JB, Muto H, Chou MC.
    Adv Cyclic Nucleotide Res; 1980 Mar; 12():359-72. PubMed ID: 6250367
    [No Abstract] [Full Text] [Related]

  • 7. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
    Islam N, Tuppal R, Hawe BS, Briones-Urbina R, Farid NR.
    J Cell Biochem; 1986 Mar; 31(2):107-20. PubMed ID: 2426288
    [Abstract] [Full Text] [Related]

  • 8. Interactions of bovine thyrotropin and preparations of human chorionic gonadotropin with bovine thyroid membranes.
    Amir SM, Uchimura H, Ingbar SH.
    J Clin Endocrinol Metab; 1977 Aug; 45(2):280-92. PubMed ID: 195974
    [No Abstract] [Full Text] [Related]

  • 9. Proceedings: Influence of human thyroid-stimulating hormone and immunoglobulins from patients with Graves' disease on human thyroid cyclic AMP.
    Holmes SD, Dirmikis SM, Martin TJ, Munro DS.
    J Endocrinol; 1976 Jun; 69(3):8P-9P. PubMed ID: 181521
    [No Abstract] [Full Text] [Related]

  • 10. Abnormal adenylate cyclase activity and altered membrane gangliosides in thyroid cells from patients with Graves' disease.
    Lee G, Grollman EF, Aloj SM, Kohn LD, Winand RJ.
    Biochem Biophys Res Commun; 1977 Jul 11; 77(1):139-46. PubMed ID: 578114
    [No Abstract] [Full Text] [Related]

  • 11. In vitro demonstration of normal thyrotropin (TSH) responsiveness in thyroid tissue from patients with Graves' disease.
    Field JB, Larsen PR, Yamashita K.
    Trans Assoc Am Physicians; 1973 Jul 11; 86():300-9. PubMed ID: 4363386
    [No Abstract] [Full Text] [Related]

  • 12. Effect of iodine enrichment in vitro on the adenylate cyclase-adenosine 3',5' monophosphate system in thyroid glands from normal subjects and patients with Graves' disease.
    Uchimura H, Chiu SC, Kuzaya N, Ikeda H, Ito K, Nagataki S.
    J Clin Endocrinol Metab; 1980 Jun 11; 50(6):1066-70. PubMed ID: 6246144
    [No Abstract] [Full Text] [Related]

  • 13. The effect of sialic acid on adenylate cyclase activity and thyrotropin-receptor binding in human thyroid membranes.
    Adler GM.
    Acta Biochim Pol; 1978 Jun 11; 25(4):343-7. PubMed ID: 220831
    [Abstract] [Full Text] [Related]

  • 14. [Examples of biochemical lesions in the loss of hormone dependence in thyroid tumors].
    Macchia V, Mariano A.
    Minerva Med; 1986 Nov 17; 77(44):2035-8. PubMed ID: 3785716
    [No Abstract] [Full Text] [Related]

  • 15. Alterations in TSH-receptor in two transplantable rat thyroid tumors.
    Macchia V, Meldolesi MF, Mandato E.
    Ann Radiol (Paris); 1977 Nov 17; 20(8):752-6. PubMed ID: 205162
    [No Abstract] [Full Text] [Related]

  • 16. Receptor-binding regions in human glycoprotein hormones.
    Keutmann HT.
    Mol Cell Endocrinol; 1992 Jul 17; 86(1-2):C1-6. PubMed ID: 1380927
    [No Abstract] [Full Text] [Related]

  • 17. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
    Baker JR, Lukes YG, Smallridge RC, Berger M, Burman KD.
    J Clin Invest; 1983 Oct 17; 72(4):1487-97. PubMed ID: 6138364
    [Abstract] [Full Text] [Related]

  • 18. Evidence for normal thyroidal adenyl cyclase, cyclic AMP-binding and protein-kinase activities in Graves' disease.
    Orgiazzi J, Chopra IJ, Williams DE, Solomon DH.
    J Clin Endocrinol Metab; 1975 Feb 17; 40(2):248-55. PubMed ID: 165418
    [Abstract] [Full Text] [Related]

  • 19. Receptor-specific activity of heteromeric thyrotropin (TSH) analogs: development of synthetic TSH antagonists.
    Sheehan MT, Morbeck DE, Bergert ER, McCormick DJ, Milius RP, Morris JC.
    Pept Res; 1995 Feb 17; 8(5):264-71. PubMed ID: 8589548
    [Abstract] [Full Text] [Related]

  • 20. Point mutations of the thyrotropin receptor determining structural requirements for its ability to bind thyrotropin and to stimulate adenylate cyclase activity.
    Gustavsson B, Westermark B, Heldin NE.
    Biochem Biophys Res Commun; 1994 Mar 15; 199(2):612-8. PubMed ID: 8135801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.